Vortioxetine hydrobromide
-
Post Date:
Mar 22,2016
-
Expiry Date:
Sep 18,2016
-
Detailed Description:
Cas No. :508233-74-7
Vortioxetine hydrobromide
CAS 508233-74-7
White powder
Assay: 99%
Chemical name: 1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]-piperazine, hydrobromide
Description
Vortioxetine hydrobromide is indicated for the treatment of major depressive disorder (MDD) 。
The recommended starting dose is 10 mg administered orally once daily without regard to meals.
The dose should then be increased to 20 mg/day, as tolerated.
Consider 5 mg/day for patients who do not tolerate higher doses .
Vortioxetine can be discontinued abruptly. However, it is recommended that doses of 15 mg/day or 20 mg/day be reduced to 10 mg/day for one week prior to full discontinuation if possible.
The maximum recommended dose is 10 mg/day in known CYP2D6 poor metabolizers.
-
CAS Registry Number:
508233-74-7
-
Synonyms:
;1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine;1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine;1-(2-(2.4-dimeethylphenylthio)pheny1) piperazine;
-
Molecular Formula:
C18H22N2S
-
Molecular Weight:
298.445709
-
Molecular Structure:
Inquiry